An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University Of Bern”.
The original version of this article has been updated.
. 2023 Mar 21;14:1183189. doi: 10.3389/fimmu.2023.1183189
Erratum: Virus-like particles are efficient tools for boosting mRNA-induced antibodies
Frontiers Production Office1,*
1
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
Received 2023 Mar 9; Accepted 2023 Mar 9; Collection date 2023.
Keywords: SARS-CoV-2, vaccine, virus-like particles, mRNA, COVID-19
Copyright © 2023 Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC10071270 PMID: 37025996
This corrects the article "Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies" in volume 13, 864718.